SCHEMBL23725835

SCHEMBL23725835

Cc1c(N)cccc1-c1cccc(-c2ccn3c(=O)c(CN(CCO)C(=O)OC(C)(C)C)cnc3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 9/20 0.36
▸ FGFR3 P22607 8/20 0.36
▸ SSTR4 P31391 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ BRD4 O60885 1/20 0.31
▸ NEK2 P51955 2/20 0.31
▸ PKM P14618 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2A1 P68400 1/20 0.31
▸ GABRA1 P14867 1/20 0.30
▸ GABRG2 P18507 1/20 0.30
▸ GABRB3 P28472 1/20 0.30
▸ GABRA5 P31644 1/20 0.30
▸ GABRA3 P34903 1/20 0.30
▸ GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25664063 0.91 SSTR4 (0.38) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL25664062 0.90 SSTR4 (0.37) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL25168028 0.89 KDR (0.35) KDRFGFR3KDM4EALDH1A1GAA
SCHEMBL25168867 0.88 SSTR4 (0.42) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL30432339 0.88 SSTR4 (0.42) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL25168030 0.85 SSTR4 (0.42) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL30433252 0.85 SSTR4 (0.42) KDRFGFR3SSTR4KDM4EALDH1A1
SCHEMBL25664050 0.84 PDCD1 (0.39) KDRFGFR3SSTR4TRPV1NEK2
SCHEMBL25175460 0.84 PDCD1 (0.45) PDCD1CD274
SCHEMBL30432664 0.83 SSTR4 (0.33) KDRFGFR3SSTR4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 — — US disclosed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 — — US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 — — EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 — — CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDR 3652/4885FGFR3 777/4885SSTR4 3227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback